Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q2 2025 Earnings Call Transcript August 11, 2025
Xenon Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-1.07 EPS, expectations were $-1.03.
Operator: Thank you for standing by. At this time, I would like to welcome everyone to Xenon Pharmaceuticals Second Quarter 2025 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to Chad Fugere. You may begin.
Chad Fugere: Good afternoon. Thank you for...
